Evidence map›Paper›PMID 30050450›Full record

ArticleFrontiers in physiology2018

F

Helen Tanton, Svetlana Voronina, Anthony Evans, Jane Armstrong, Robert Sutton, David N Criddle, Lee Haynes, Michael C Schmid, Fiona Campbell, Eithne Costello and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Helen TantonDepartment of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom.
Svetlana VoroninaDepartment of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom.
Anthony EvansDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Jane ArmstrongDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Robert SuttonDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
David N CriddleDepartment of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom.
Lee HaynesDepartment of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom.
Michael C SchmidDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Fiona CampbellDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Eithne CostelloDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom.
Alexei V TepikinDepartment of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom.
University of Liverpool · GB

Funding

Department of Health EME/15/20/01Medical Research Council MR/L000512/1Medical Research Council MR/P018920/1Wellcome Trust
6 · The paper itself

Abstract

F

Indexed as

ATPbioenergeticsF1F0-ATP synthase inhibitory factor 1mitochondrial membrane potentialpancreatic acinar cellspancreatic ductal adenocarcinoma

Identifiers

PMID30050450
PMCPMC6050379
OpenAlexW2808299461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.